https://www.ncbi.nlm.nih.gov/Structure/pdb/6RQM
6RQM: A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4
A blocking anti-CTLA-4 nanobody (KN044)Cytotoxic T-lymphocyte protein 4
anti ctla 4blockingnanobody
https://pmc.ncbi.nlm.nih.gov/articles/PMC6239932/
Synthetic DNA-encoded monoclonal antibody delivery of anti-CTLA-4 antibodies induces tumor...
Antibody-based immune therapies targeting the T cell checkpoint molecules CTLA-4 and PD-1 have impacted cancer therapy. However, this immune therapy requires...
anti ctla 4
https://www.epo.org/en/boards-of-appeal/decisions/t121351eu1
T 1351/12 (Anti-CTLA-4 based immunotherapy/SQUIBB) of 16.07.2018
anti ctla 4